利用每日性激素复合摘要评估至绝经时间:聚焦孕烷二醇葡萄糖醛酸苷(PDG)
研究纳入549名中年女性的一个完整月经周期,每日检测尿LH、FSH、雌激素结合物(E1C)和孕烷二醇葡萄糖醛酸苷(PDG),以模糊熵和标准化动态时间规整距离(DTW)刻画激素轨迹。聚类分析和Cox比例风险分析显示,PDG在DTW/模糊熵平面上可区分至末次月经时间(FMP)的生存曲线,且校正已知协变量后仍持续。结论认为PDG此前未被视作卵巢衰老的预测指标,本研究验证了DTW/模糊熵分析框架并引入新的激素指标用于FMP相关预防保健。
要点
- PDG在DTW/模糊熵平面上是至FMP时间的强预测/描述指标。
- 聚类分析显示PDG离散化后生存曲线有统计学差异,Cox分析校正协变量后仍持续。
- PDG通常不被视为卵巢衰老预测指标,本研究引入其用于FMP相关预防保健。
核心结论
- PDG在DTW/模糊熵分析框架下是至FMP时间的强预测/描述指标,该框架得到验证并引入新的激素指标用于FMP相关预防保健。
研究设计与样本
- 作为Study of Women's Health Across the Nation的一部分,对549名多种族中年女性在一个完整月经周期内每日测量尿LH、FSH、E1C和PDG。
- 将激素轨迹映射到以模糊熵和标准化动态时间规整距离(DTW)为轴的平面上,DTW距离以绝经前/稳定周期模式(教科书金标准,GS)为参照。
主要发现
- 通过DTW/模糊熵平面观察FSH、E1C、PDG和LH,与现有认识相反,PDG突出为至FMP时间的强预测/描述指标。
- 使用聚类分析在DTW/模糊熵平面上离散化PDG,得到统计学不同的生存曲线。
- Cox比例风险分析确认,在纳入FSH、抗苗勒管激素、年龄、体重指数、经济困难、吸烟状况和周期长度等已知协变量后,该分离仍持续。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The timing of a woman's final menstrual period (FMP) in relation to her age is considered a valuable indicator of overall health, being associated with cardiovascular, bone health, reproductive, and general mortality outcomes. OBJECTIVE: This work aimed to evaluate the relationship between hormones and the "time to FMP" when daily hormone trajectories are characterized by their 1) entropy, and 2) deviation from premenopausal/stable cycle patterns (representing a textbook "gold standard"; GS). METHODS: As part of the Study of Women's Health Across the Nation, urinary luteinizing hormone (LH), follicle-stimulating hormone (FSH), estrogen conjugates (E1C), and pregnanediol glucuronide (PDG) were measured daily from a multiracial sample of 549 mid-life women for the duration of one menstrual cycle. Hormone trajectories were mapped onto a plane with axes representing Fuzzy entropy (FuzzEn) and the normalized dynamic time warping distance (DTW) from the GS. RESULTS: Viewing FSH, E1C, PDG, and LH through this lens reveals that, contrary to existing wisdom, PDG stands out as a powerful predictor/descriptor of "time to FMP." Using cluster analyses to discretize PDG on the DTW/FuzzEn plane yields statistically different survival curves, and Cox proportional hazards analyses confirm that this separation persists in the presence of known covariates of FSH, antimüllerian hormone, age, body mass index, financial hardship, smoking status, and cycle length. CONCLUSION: Since PDG is generally not considered a predictor/descriptor of ovarian aging, this work validates the DTW/FuzzEn analytical framework and introduces another metric/hormone to be used in FMP-related preventive care.
引用
- Winkles JF, Colvin A, El Khoudary SR, et al. Using a Composite Summary of Daily Sex Hormones to Gauge Time Until Menopause: A Focus on Pregnanediol Glucuronide (PDG). J Clin Endocrinol Metab. 2025. PMID: 39847409. doi:10.1210/clinem/dgae895
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。